Hernia, Inguinal
2
Pipeline Programs
3
Companies
3
Clinical Trials
2 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
SinteticaSwitzerland - Mendriosi
1 program1
Chloroprocaine 1% Injectable SolutionPhase 21 trial
Active Trials
M&
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Calicolocal anaesthetic injection
SinteticaChloroprocaine 1% Injectable Solution
Merck & Co.Level of pneumoperitoneum 12-9-6 mmHg
Clinical Trials (3)
Total enrollment: 190 patients across 3 trials
Herniorrhaphy for Postoperative Pain
Start: Apr 2023Est. completion: Dec 2024
Phase 3Recruiting
The Efficacy and Safety of Chloroprocaine 1% and 2% in Pediatric Population
Start: Feb 2019Est. completion: Dec 2024174 patients
Phase 2Recruiting
Validation of a Subjective Rating Scale for Assessment of the Surgical Workspace in Laparoscopy
Start: Mar 2016Est. completion: Aug 201616 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
2 actively recruiting trials targeting 190 patients
3 companies competing in this space